249 related articles for article (PubMed ID: 2153395)
1. Expression of the oestrogen regulated pNR-2 mRNA in human breast cancer: relation to oestrogen receptor mRNA levels and response to tamoxifen therapy.
Henry JA; Nicholson S; Hennessy C; Lennard TW; May FE; Westley BR
Br J Cancer; 1990 Jan; 61(1):32-8. PubMed ID: 2153395
[TBL] [Abstract][Full Text] [Related]
2. pNR-2/pS2 immunohistochemical staining in breast cancer: correlation with prognostic factors and endocrine response.
Henry JA; Piggott NH; Mallick UK; Nicholson S; Farndon JR; Westley BR; May FE
Br J Cancer; 1991 Apr; 63(4):615-22. PubMed ID: 1850611
[TBL] [Abstract][Full Text] [Related]
3. Oestrogenic activity of tamoxifen and its metabolites on gene regulation and cell proliferation in MCF-7 breast cancer cells.
Johnson MD; Westley BR; May FE
Br J Cancer; 1989 May; 59(5):727-38. PubMed ID: 2736207
[TBL] [Abstract][Full Text] [Related]
4. Effects of oestrogen and the antioestrogens, tamoxifen and LY117018, on four oestrogen-regulated RNAs in the EFM-19 breast cancer cell line.
Westley BR; Hölzel F; May FE
J Steroid Biochem; 1989 Mar; 32(3):365-72. PubMed ID: 2468045
[TBL] [Abstract][Full Text] [Related]
5. Measurement of oestrogen receptor mRNA levels in human breast tumours.
Henry JA; Nicholson S; Farndon JR; Westley BR; May FE
Br J Cancer; 1988 Nov; 58(5):600-5. PubMed ID: 2851309
[TBL] [Abstract][Full Text] [Related]
6. Transforming growth factor beta 1 is implicated in the failure of tamoxifen therapy in human breast cancer.
Thompson AM; Kerr DJ; Steel CM
Br J Cancer; 1991 Apr; 63(4):609-14. PubMed ID: 2021547
[TBL] [Abstract][Full Text] [Related]
7. Treatment of lymph-node-negative, oestrogen-receptor-positive breast cancer: long-term findings from National Surgical Adjuvant Breast and Bowel Project randomised clinical trials.
Fisher B; Jeong JH; Bryant J; Anderson S; Dignam J; Fisher ER; Wolmark N;
Lancet; 2004 Sep 4-10; 364(9437):858-68. PubMed ID: 15351193
[TBL] [Abstract][Full Text] [Related]
8. Beneficial effect of adjuvant tamoxifen therapy in primary breast cancer patients with high oestrogen receptor values.
Rose C; Thorpe SM; Andersen KW; Pedersen BV; Mouridsen HT; Blichert-Toft M; Rasmussen BB
Lancet; 1985 Jan; 1(8419):16-9. PubMed ID: 2856949
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic effect of tamoxifen related to estrogen receptor level.
Rose C; Thorpe SM; Løber J; Daenfeldt JL; Palshof T; Mouridsen HT
Recent Results Cancer Res; 1980; 71():134-41. PubMed ID: 6988911
[TBL] [Abstract][Full Text] [Related]
10. Oestrogen-receptor status and endocrine therapy of breast cancer: response rates and status stability.
Leake RE; Laing L; Calman KC; Macbeth FR; Crawford D; Smith DC
Br J Cancer; 1981 Jan; 43(1):59-66. PubMed ID: 7459239
[TBL] [Abstract][Full Text] [Related]
11. Oestrogen receptors and the response of metastatic breast cancer to aminoglutethimide or tamoxifen.
Holdaway IM
Aust N Z J Surg; 1981 Aug; 51(4):345-7. PubMed ID: 6944051
[TBL] [Abstract][Full Text] [Related]
12. Antipeptide antibodies against the pNR-2 oestrogen-regulated protein of human breast cancer cells and detection of pNR-2 expression in normal tissues by immunohistochemistry.
Piggott NH; Henry JA; May FE; Westley BR
J Pathol; 1991 Feb; 163(2):95-104. PubMed ID: 1707960
[TBL] [Abstract][Full Text] [Related]
13. High progesterone receptor concentration in a variant of the ZR-75-1 human breast cancer cell line adapted to growth in oestrogen free conditions.
van den Berg HW; Martin J; Lynch M
Br J Cancer; 1990 Apr; 61(4):504-7. PubMed ID: 2139575
[TBL] [Abstract][Full Text] [Related]
14. Relationship of coregulator and oestrogen receptor isoform expression to de novo tamoxifen resistance in human breast cancer.
Murphy LC; Leygue E; Niu Y; Snell L; Ho SM; Watson PH
Br J Cancer; 2002 Dec; 87(12):1411-6. PubMed ID: 12454770
[TBL] [Abstract][Full Text] [Related]
15. Determination of oestrogen responsiveness of breast cancer by competitive reverse transcription-polymerase chain reaction.
Carr M; May FE; Lennard TW; Westley BR
Br J Cancer; 1995 Dec; 72(6):1427-34. PubMed ID: 8519655
[TBL] [Abstract][Full Text] [Related]
16. The relationship between the insulin-like growth factor-1 system and the oestrogen metabolising enzymes in breast cancer tissue and its adjacent non-cancerous tissue.
Chong YM; Colston K; Jiang WG; Sharma AK; Mokbel K
Breast Cancer Res Treat; 2006 Oct; 99(3):275-88. PubMed ID: 16752221
[TBL] [Abstract][Full Text] [Related]
17. Relation between immunocytochemical estimation of oestrogen receptor in elderly patients with primary breast cancer and response to tamoxifen.
Gaskell DJ; Hawkins RA; Sangsterl K; Chetty U; Forrest AP
Lancet; 1989 May; 1(8646):1044-6. PubMed ID: 2566000
[TBL] [Abstract][Full Text] [Related]
18. Expression of human intestinal trefoil factor in malignant cells and its regulation by oestrogen in breast cancer cells.
May FE; Westley BR
J Pathol; 1997 Aug; 182(4):404-13. PubMed ID: 9306961
[TBL] [Abstract][Full Text] [Related]
19. Expression of prolactin receptor mRNA in oestrogen receptor positive breast cancers pre- and post-tamoxifen therapy.
de Castillo B; Cawthorn S; Moppett J; Shere M; Norman M
Eur J Surg Oncol; 2004 Jun; 30(5):515-9. PubMed ID: 15135479
[TBL] [Abstract][Full Text] [Related]
20. DNA analysis by flow cytometry, response to endocrine treatment and prognosis in advanced carcinoma of the breast.
Baildam AD; Zaloudik J; Howell A; Barnes DM; Turnbull L; Swindell R; Moore M; Sellwood RA
Br J Cancer; 1987 May; 55(5):553-9. PubMed ID: 3038158
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
